The company said, “Ceribell (CBLL) is raising its revenue guidance for the full year 2025 to a range of $83 million to $87 million, representing growth of approximately 27% to 33% over the company’s prior year revenue.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBLL:
- Ceribell reports Q1 EPS (36c), consensus (46c)
- Ceribell announces EEG system received full RedRAMP High authorization
- Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating
- Ceribell announces FDA grants clearance for next-gen Ceribell Clarity algorithm
- Ceribell jumps after saying no impact from incremental tariffs until Q4
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue